Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

NCT01134315 · clinicaltrials.gov ↗

TERMINATED

Status

61

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated after FDA agreement.

Conditions

Secondary Hyperparathyroidism
End-Stage Renal Disease

Interventions

DRUG: Paricalcitol
DRUG: Calcitriol

Sponsor

AbbVie (prior sponsor, Abbott)

Collaborators

[object Object]